Brief: Eterna Therapeutics Inc Reports Net Loss For Q4 Of 2022 Of $4.5 Million, Or $1.24 Per Share

Ernexa Therapeutics

20/03/2023 20:23

March 20 (Reuters) - Eterna Therapeutics Inc  ERNA.O :
    * ETERNA THERAPEUTICS REPORTS FINANCIAL RESULTS FOR FOURTH
QUARTER
AND FULL YEAR 2022 AND RECENT BUSINESS HIGHLIGHTS
    * ETERNA THERAPEUTICS INC - NET LOSS FOR Q4 OF 2022 WAS $4.5
MILLION, OR $1.24 PER SHARE

Source text for Eikon:  ID:nGNXbxp3Vy 
Further company coverage:  ERNA.O 

 ((Reuters.Briefs@thomsonreuters.com;;))